ACTIVE

WYETH LEDERLE VACCINES

Export PDF

Financial year 2025 · Closed on 30/11/2025

Net result2,1 k €-86,8 %over 1 year

Equity510,1 k €+0,4 %over 1 year

Identity

Source · BCE/KBO

WYETH LEDERLE VACCINES is a Public limited company incorporated in 1997. Its registered office is in Ixelles.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0460.950.631
Incorporation: 27/06/1997
Legal form: Public limited company
Registered office: Boulevard de la Plaine 17
1050 Ixelles · BruxellesSee on map
Contributed capital: 62 000,00 €
Latest accounts: 30/11/2025

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflow

Financials

Source · NBB, 21 filings

Trend over 17 financial years

	2025		2024		2023		2022		2021
Income statement
EBITDA	-8,7 k €	-253%	-2,5 k €	+11.1%	-2,8 k €	+8.8%	-3 k €	-23.1%	-2,5 k €
Operating result	-8,7 k €	-253%	-2,5 k €	+11.1%	-2,8 k €	+8.8%	-3 k €	-23.1%	-2,5 k €
Net result	2,1 k €	-86.8%	15,5 k €	+41.1%	11 k €	+326%	-4,9 k €	+20.2%	-6,1 k €
Balance sheet
Equity	510,1 k €	+0.4%	508,1 k €	+3.1%	492,6 k €	+2.3%	481,6 k €	-1.0%	486,5 k €
Total assets	516 k €	+1.1%	510,5 k €	+3.1%	495,3 k €	+2.3%	484,2 k €	-0.5%	486,5 k €
Cash	26,7 k €	-48.0%	51,4 k €	+1487%	3,2 k €	-45.4%	5,9 k €	-10.1%	6,6 k €
Debts	2,4 k €	+120600%	2 €	-99.9%	2,4 k €		–		64 €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 30/11/2015

2 active · 14 ended

Last known composition, from the accounts closed on 30/11/2015, more than two years before the latest accounts. The mandates shown may have expired.

Active mandates

Didier Vinel

Director · since 20 mai 2015 · until 16 mai 2018

Active

Karel Van De Sompel

Managing director · since 20 mai 2015 · until 16 mai 2018

Active

Ended mandates

Didier Vinel

Director · since 01 avril 2012 · until 20 mai 2015

Ended

Karel Van De Sompel

Managing director · since 01 mars 2012 · until 20 mai 2015

Ended

Etienne Catthoor

Director · since 19 novembre 2009 · until 01 mars 2012

Ended

Etienne Catthoor

Managing director · since 19 novembre 2009 · until 04 mai 2015

Ended

Other companies at this address

Boulevard de la Plaine 17 1050 Ixelles

Company	CBE no.
HOSPIRA BENELUX● Active	0449.591.040
Pfizer● Active	0401.994.823
PFIZER EUROPE MA EEIG● Active	0696.658.156

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/12/2024	01/12/2023	01/12/2022	01/12/2021	01/12/2020	01/12/2019
Closing of the financial year	30/11/2025	30/11/2024	30/11/2023	30/11/2022	30/11/2021	30/11/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/06/2026	23/05/2025	21/05/2024	23/05/2023	01/06/2022	31/05/2021
General meeting	20/05/2026	05/05/2025	06/05/2024	02/05/2023	02/05/2022	19/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	30/11/2025	20/05/2026	02/06/2026	French	PDF
Full model	30/11/2024	05/05/2025	23/05/2025	French	PDF
Full model	30/11/2023	06/05/2024	21/05/2024	French	PDF
Full model	30/11/2022	02/05/2023	23/05/2023	French	PDF
Full model	30/11/2021	02/05/2022	01/06/2022	French	PDF
Full model	30/11/2020	19/05/2021	31/05/2021	French	PDF
Full model	30/11/2019	20/05/2020	29/06/2020	French	PDF
Full model	30/11/2018	15/05/2019	22/05/2019	French	PDF
Full model	30/11/2017	16/05/2018	30/05/2018	French	PDF
Full model	30/11/2016	17/05/2017	09/06/2017	French	PDF
Full model	30/11/2015	18/05/2016	13/06/2016	French	PDF
Full model	30/11/2014	20/05/2015	22/06/2015	French	PDF
Full model	30/11/2013	21/05/2014	26/06/2014	French	PDF
Full model	30/11/2012	06/05/2013	27/06/2013	French	PDF
Full model	30/11/2011	09/05/2012	19/06/2012	French	PDF
Full model	30/11/2010	14/06/2011	09/08/2011	French	PDF
Full model	30/11/2009	17/05/2010	20/05/2010	French	PDF
Full modelCorrection	31/12/2008	24/08/2009	16/09/2009	French	PDF
Full model	31/12/2008	04/06/2009	01/07/2009	French	PDF
Full model	31/12/2007	10/07/2008	22/07/2008	French	PDF
Full model	31/12/2006	16/08/2007	28/11/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/11/2015

2 active · 14 ended

Last known composition, from the accounts closed on 30/11/2015, more than two years before the latest accounts. The mandates shown may have expired.

Active mandates

Didier Vinel

Director · since 20 mai 2015 · until 16 mai 2018

Active

Karel Van De Sompel

Managing director · since 20 mai 2015 · until 16 mai 2018

Active

Ended mandates

Didier Vinel

Director · since 01 avril 2012 · until 20 mai 2015

Ended

Karel Van De Sompel

Managing director · since 01 mars 2012 · until 20 mai 2015

Ended

Etienne Catthoor

Director · since 19 novembre 2009 · until 01 mars 2012

Ended

Etienne Catthoor

Managing director · since 19 novembre 2009 · until 04 mai 2015

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates19/01/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates05/05/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates09/07/2024
DEMISSIONS, NOMINATIONS
PDF
Other07/12/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Other11/05/2023
DIVERS
PDF
Mandates06/12/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates19/08/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates03/08/2021
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 20252,1 k €↓
2024
Annual accounts 202415,5 k €↑
2023
Annual accounts 202311 k €↑
2022
Annual accounts 2022-4,9 k €↑
2021
Annual accounts 2021-6,1 k €↓
2020
Annual accounts 2020-5,6 k €↓
2019
Annual accounts 2019-2,8 k €↓
2018
Annual accounts 2018-2,7 k €↑
2017
Annual accounts 2017-3,6 k €↑
2015
Annual accounts 2015-4,2 k €↑
2014
Annual accounts 2014-5,7 k €↓
2013
Annual accounts 2013-4,2 k €↑
2012
Annual accounts 2012-5,2 k €↓
2011
Annual accounts 201131,2 k €↓
2010
Annual accounts 201063 k €↑
2009
Annual accounts 200924,2 k €↓
2008
Annual accounts 200884,3 k €
27/06/1997
IncorporationPublic limited company

WYETH LEDERLE VACCINES

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline